Quick answer
What does non-HDL cholesterol mean?
Non-HDL cholesterol equals total cholesterol minus HDL cholesterol. It represents cholesterol carried by LDL plus other ApoB-containing particles that can contribute to atherosclerosis. It is calculated from a standard lipid panel, works for most fasting or nonfasting samples and can remain informative when triglycerides make an LDL estimate less certain. A commonly cited healthy-population benchmark is below 130 mg/dL (3.4 mmol/L), but current treatment goals are risk based and can be substantially lower. Use the goal set for the person's cardiovascular risk rather than treating 130 as universal.See reference 1,See reference 2,See reference 3,See reference 4
The essentials in nine points
- The formula is non-HDL-C = total cholesterol − HDL-C, using values from the same sample and in the same unit.See reference 1,See reference 3
- The result includes cholesterol carried in LDL, VLDL, IDL, lipoprotein(a) and remnant particles rather than measuring one particle type.See reference 1
- The 2026 ACC/AHA guideline recommends reporting non-HDL-C for risk assessment and for starting and monitoring lipid-lowering treatment.See reference 1,See reference 2
- A standard fasting or nonfasting lipid profile is suitable for most people.See reference 1,See reference 4
- Fasting becomes more useful when triglycerides are very high, a genetic lipid disorder is suspected or the clinical question needs a fasting repeat.See reference 1
- Non-HDL-C is not the same as LDL-C; it intentionally includes a broader set of atherogenic cholesterol carriers.See reference 1,See reference 3
- ApoB counts atherogenic particles, while non-HDL-C measures their cholesterol cargo; discordance can add useful information.See reference 1,See reference 2
- Treatment goals depend on absolute cardiovascular risk and existing disease, not a single population reference interval.See reference 1,See reference 2,See reference 4
- One result should be interpreted with triglycerides, LDL-C, ApoB when indicated, lipoprotein(a), blood pressure, diabetes, kidney health, smoking and treatment history.See reference 1,See reference 2,See reference 4
How to calculate non-HDL cholesterol correctly
| Step | Example | Boundary |
|---|---|---|
| Use total cholesterol and HDL-C from the same blood sample | Total 200 mg/dL and HDL 50 mg/dL | Do not mix results from different dates or clinical states.See reference 1,See reference 3 |
| Subtract HDL-C from total cholesterol | 200 − 50 = 150 mg/dL | Keep both inputs in the same unit.See reference 1,See reference 3 |
| The same arithmetic works in mmol/L | 5.2 − 1.3 = 3.9 mmol/L | Do not subtract an mg/dL value from a mmol/L value.See reference 1,See reference 3 |
| Report a concentration, not a ratio | 150 mg/dL | Non-HDL-C is different from total/HDL ratio.See reference 1,See reference 3 |
| Use the laboratory-reported result when available | The lab may calculate it automatically | Avoid inventing extra decimal precision.See reference 1 |
What non-HDL includes that LDL alone can miss
| Component | What non-HDL captures | Interpretation note |
|---|---|---|
| LDL particles | Their cholesterol is the largest component for many people | LDL-C remains a primary treatment measure.See reference 1,See reference 4 |
| VLDL, IDL and remnant particles | Cholesterol carried outside HDL and LDL | Especially relevant when triglycerides are elevated.See reference 1 |
| Lipoprotein(a) | Its cholesterol contributes to non-HDL-C | The 2026 guideline recommends measuring Lp(a) at least once because non-HDL cannot identify how much risk comes from Lp(a).See reference 1,See reference 2 |
| All ApoB-containing particles | Their combined cholesterol cargo | ApoB measures particle number, not cholesterol mass, and can clarify residual risk in selected people.See reference 1,See reference 2 |
A benchmark is not the same as a personal treatment goal
| Situation | How to read the number | Why the goal differs |
|---|---|---|
| General healthy-population context | Below 130 mg/dL (3.4 mmol/L) is a commonly cited benchmark | It is a screening reference, not permission to ignore other risks.See reference 3 |
| Primary prevention | Use the current risk estimate and clinician-patient decision | Age, blood pressure, diabetes, kidney disease, smoking, family history, LDL-C and risk enhancers change the benefit of treatment.See reference 1,See reference 2 |
| Known atherosclerotic cardiovascular disease | Goals are lower than general-population benchmarks | Risk of another event is higher and treatment intensity is greater.See reference 1,See reference 2 |
| Very-high-risk secondary prevention | The 2026 guideline recommends non-HDL-C below 85 mg/dL (2.2 mmol/L) | This is a treatment goal for a defined high-risk group, not a universal normal range.See reference 1,See reference 2 |
| Already taking lipid-lowering therapy | Compare with the person's goal and percent LDL-C reduction | A single threshold cannot show adherence, response or residual ApoB risk.See reference 1,See reference 2 |
Do you need to fast?
For most adults and children, the 2026 guideline recommends a standard fasting or nonfasting lipid profile. Non-HDL-C is robust because it uses directly measured total and HDL cholesterol, and fasting and nonfasting values have similar long-term prognostic value in most people.See reference 1
A fasting repeat is appropriate when a nonfasting triglyceride result is 400 mg/dL (4.5 mmol/L) or higher, and may help when a triglyceride disorder or premature familial disease is suspected. Follow the ordering clinician and laboratory instructions rather than fasting by default.See reference 1
When non-HDL, LDL and ApoB disagree
| Pattern | Possible meaning | Useful next step |
|---|---|---|
| Non-HDL higher than expected from LDL-C | More cholesterol may be carried in triglyceride-rich remnants | Review triglycerides, diabetes, weight, alcohol, thyroid and secondary causes.See reference 1 |
| ApoB high despite achieved LDL-C/non-HDL-C goals | Many cholesterol-depleted atherogenic particles may remain | The guideline supports ApoB-guided intensification in selected treated adults, especially with diabetes, CKM syndrome, ASCVD or elevated triglycerides.See reference 1,See reference 2 |
| Unexpected risk with ordinary lipid values | High lipoprotein(a) can add inherited risk | Measure Lp(a) at least once as recommended rather than trying to infer it from non-HDL-C.See reference 1,See reference 2 |
| Large unexpected change | Illness, adherence, medicine, diet, weight or laboratory conditions may differ | Verify the result and clinical state before changing treatment.See reference 1,See reference 4 |
A cholesterol number is not an emergency triage tool
High non-HDL cholesterol usually represents long-term risk, not an immediate symptom. Seek emergency care for chest pressure, severe breathlessness, fainting, sudden one-sided weakness, facial droop, trouble speaking or another possible heart attack or stroke symptom regardless of the latest cholesterol result. Do not start, stop or double lipid medicines based on an online cutoff.See reference 1,See reference 2,See reference 4
Frequently asked questions
How do I calculate non-HDL cholesterol?
Subtract HDL cholesterol from total cholesterol using the same sample and unit. For example, 200 minus 50 equals 150 mg/dL.See reference 1,See reference 3
Is non-HDL better than LDL?
They are complementary. LDL-C remains a primary treatment measure; non-HDL-C adds cholesterol carried in remnant and other ApoB particles and is recommended for risk assessment and monitoring.See reference 1,See reference 2
What is a good non-HDL result?
Below 130 mg/dL is a common healthy-population benchmark, but treatment goals depend on risk and can be much lower. Use the goal set for your risk category.See reference 1,See reference 2,See reference 3
Do I need to fast?
Usually not. A fasting repeat is important with very high nonfasting triglycerides or selected genetic and triglyceride questions.See reference 1
Is non-HDL the same as ApoB?
No. Non-HDL-C measures cholesterol mass in atherogenic particles; ApoB estimates their number. Either can be relatively higher when particles carry more or less cholesterol than usual.See reference 1,See reference 2
Can high HDL cancel high non-HDL?
No. HDL is already subtracted in the formula. A high HDL result does not erase risk from elevated ApoB-containing particles or other cardiovascular factors.See reference 1,See reference 4
References
- 1. 2026 ACC/AHA Multisociety Guideline on the Management of Dyslipidemia
CirculationGuideline
- 2. Top Things to Know: 2026 Guideline on the Management of Dyslipidemia
American Heart AssociationOfficial guidance
- 3. Blood Cholesterol — Diagnosis
National Heart, Lung, and Blood InstituteOfficial guidance
- 4. Understanding Cholesterol and Lipids
American Heart AssociationOfficial guidance
Editorial transparency
- Published by
- LongevityMate Editorial Team
- Published
- Updated
Medical disclaimer
Educational information, not diagnosis or a personal cholesterol target or treatment plan. Interpret non-HDL cholesterol with the current risk guideline, LDL-C, triglycerides, ApoB when indicated, lipoprotein(a), existing cardiovascular disease, diabetes, kidney disease, medicines and the full clinical picture. Do not change lipid-lowering treatment without the responsible clinician.